design: HCC-1428/LTED breast cancer cells in HD medium were treated with DMSO vehicle or 500 nM entinostat for 24 hours, and then treated +/- 1 nM E2 for 90 min prior to CUT&RUN to identify H3K9me-associated sites as a positive control.